<DOC>
<DOCNO>
EP-0009548
</DOCNO>
<TEXT>
<DATE>
19800416
</DATE>
<IPC-CLASSIFICATIONS>
C07D-501/24 A61P-31/00 C07D-213/75 C07D-417/12 C07D-209/48 C07F-9/6561 C07D-213/00 C07D-277/00 C07F-9/6539 C07D-277/44 <main>C07D-501/24</main> C07D-277/38 C07D-277/48 C07F-9/40 C07D-417/00 C07D-501/34 C07F-9/553 C07D-521/00 A61K-31/545 A61K-31/546 A61P-31/04 C07F-9/00 C07D-277/46 C07D-277/42 C07D-501/36 C07D-277/20 C07D-501/00 C07D-209/00 C07D-277/40 
</IPC-CLASSIFICATIONS>
<TITLE>
cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
fujisawa pharmaceutical cojp<sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd.3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp<sep>fujisawa pharmaceutical co., ltd.<sep>
</APPLICANT>
<INVENTOR>
kamiya takashi<sep>nakai yoshiharu<sep>tanaka kunihiko<sep>teraji tsutomu<sep>kamiya, takashi<sep>nakai, yoshiharu<sep>tanaka, kunihiko<sep>teraji, tsutomu<sep>kamiya, takashino. 1-11-6, furuedaisuitajp<sep>nakai, yoshiharuno. 1-7-18, zezeohtsujp<sep>tanaka, kunihikono. 2-14-12, hattorikotobuki-chotoyonakajp<sep>teraji, tsutomuno. 6-20-6, kofudai, toyono-chotoyono-gun, osaka-fujp<sep>kamiya, takashi<sep>nakai, yoshiharu<sep>tanaka, kunihiko<sep>teraji, tsutomu<sep>kamiya, takashino. 1-11-6, furuedaisuitajp<sep>nakai, yoshiharuno. 1-7-18, zezeohtsujp<sep>tanaka, kunihikono. 2-14-12, hattorikotobuki-chotoyonakajp<sep>teraji, tsutomuno. 6-20-6, kofudai, toyono-chotoyono-gun, osaka-fujp<sep>
</INVENTOR>
<ABSTRACT>
the present invention relates to new 3,7-disubstituted-3-Â­ cephem-4-carboxylic acid compounds and pharmaceutically  acceptable salts thereof.  more particularly, it relates to new  3,7-disubstituted-3- cephem-4-carboxylic acid compounds  and pharmaceutically accoptable salts thereof which have  antimicrobial activities and to processes for preparation  thereof, to pharmaceutical composition comprising the same,  and to a method of using the same therapeutically in the  treatment of infectious diseases in human being and animals.  the invention relates also to the starting derivatives and  their preparation.  
</ABSTRACT>
</TEXT>
</DOC>
